Revelation Biosciences In... (REVBW)
0.01
-0.00 (-20.63%)
At close: Jan 14, 2025, 3:50 PM
0.01
4.35%
After-hours Jan 14, 2025, 03:50 PM EST
undefined% (undefined)
| Bid | 0.01 |
| Market Cap | 4.21M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -4.773 |
| PE Ratio (ttm) | 0 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.02 |
| Volume | 14,989 |
| Avg. Volume (20D) | 0 |
| Open | 0.01 |
| Previous Close | 0.01 |
| Day's Range | 0.01 - 0.01 |
| 52-Week Range | 0.01 - 0.01 |
| Beta | undefined |
About REVBW
Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, a...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 9
Stock Exchange NASDAQ
Ticker Symbol REVBW
Website https://www.revbiosciences.com